سعر اتيلول 50مجم 20 قرص 2022

Atenolol 50 mg tablets (cardioselective beta-1 blocker, antihypertensive), pack of 20 tablets (2 strips), Pharco.

• Management of hypertension.Population: Adultselectronic medicines compendium (eMC), UK
• Management of angina pectoris.Population: Adultselectronic medicines compendium (eMC), UK
• Management of cardiac arrhythmias (oral maintenance after intravenous control).Population: Adultselectronic medicines compendium (eMC), UK

• Common: bradycardia, cold extremities, gastrointestinal disturbances, fatigue. Uncommon: sleep disturbances, elevated transaminases. Rare: purpura, thrombocytopenia, mood changes, nightmares, confusion, psychoses/hallucinations, dizziness, headache, paraesthesia, dry eyes, visual disturbances, heart failure deterioration, heart block, postural hypotension, Raynaud's phenomenon, bronchospasm in asthmatics, dry mouth, hepatic toxicity, alopecia, psoriasiform reactions, rash, impotence.International label, equivalent formulation · electronic medicines compendium (eMC), UK

• Hypersensitivity to atenolol or any excipient; cardiogenic shock; uncontrolled heart failure; sick sinus syndrome; second- or third-degree heart block; untreated phaeochromocytoma; metabolic acidosis; bradycardia (<45 bpm); hypotension; severe peripheral arterial circulatory disturbances.International label, equivalent formulation · electronic medicines compendium (eMC), UK

• Do not withdraw abruptly; withdraw gradually over 7-14 days, especially in ischaemic heart disease. If stopped before surgery, discontinue at least 24 hours before; if continued, choose an anaesthetic with little negative inotropic activity.International label, equivalent formulation · electronic medicines compendium (eMC), UK
• May be used in controlled heart failure with caution (poor cardiac reserve); may increase angina attacks in Prinzmetal's angina; may aggravate less severe peripheral arterial disease; caution in first-degree heart block; reduce dose if symptomatic bradycardia (pulse <50-55 bpm at rest).International label, equivalent formulation · electronic medicines compendium (eMC), UK
• May mask symptoms of hypoglycaemia (particularly tachycardia) and signs of thyrotoxicosis; with sulfonylureas the risk of severe hypoglycaemia may increase.International label, equivalent formulation · electronic medicines compendium (eMC), UK

• Verapamil, diltiazem (negatively inotropic calcium channel blockers)Exaggerated effects with possible severe hypotension, bradycardia and cardiac failure; neither drug should be given IV within 48 hours of stopping the other.electronic medicines compendium (eMC), UK
• Dihydropyridines (e.g. nifedipine)Increased risk of hypotension; cardiac failure may occur in latent cardiac insufficiency.electronic medicines compendium (eMC), UK
• Digitalis glycosides; class I antiarrhythmics (e.g. disopyramide); amiodaroneIncreased atrioventricular conduction time and/or negative inotropic effect.electronic medicines compendium (eMC), UK

• Crosses the placenta; no first-trimester studies and fetal injury cannot be excluded; use in mild-moderate hypertension in pregnancy has been associated with intra-uterine growth retardation; weigh benefit against risk, particularly in the first and second trimesters.International label, equivalent formulation · electronic medicines compendium (eMC), UK
• Significant accumulation in breast milk; neonates of mothers receiving atenolol at parturition or breastfeeding may be at risk of hypoglycaemia and bradycardia; use with caution.International label, equivalent formulation · electronic medicines compendium (eMC), UK

• Atenolol: Beta1-selective beta-adrenergic receptor blocker without membrane-stabilizing or intrinsic sympathomimetic activity; selectivity is not absolute and higher doses also inhibit beta2 receptors (US label).